Your Inspection Readiness Program Is Probably Starting Too Late

Ask most sponsors when inspection readiness begins, and you’ll hear something like: “Once the submission is filed,” or “When the agency sends the notification.” By then, the most important work is already behind you.

An inspection doesn’t test how well you prepared in the last three months. It tests how the trial was run over the last three years.

Readiness is not a project. It’s a by-product of how you work.

When readiness starts late, it turns into a scramble to fix things that can no longer be fixed. Documents get “cleaned up,” gaps get explained rather than closed, and teams rehearse answers to questions they’ve never had to think about before. Inspectors notice. They are experienced at telling a well-run study from a well-rehearsed one.

Common signs the program has started too late

• Your first mock inspection is your first real look at the gaps. If the first independent review happens after database lock, every finding is now a remediation exercise, not a prevention opportunity.
• Vendor oversight is on paper, not in practice. Critical vendors and systems, especially those handling primary endpoints, are often the weakest link. Oversight that begins at inspection notification is too late to show control.
• Only the usual suspects have been trained. Inspectors do not only speak to the quality lead. They speak to the CRA, the data manager, the medical monitor and the site coordinator. If those people have not practised explaining their decisions clearly and consistently, the story will unravel under pressure.
• Nobody owns the narrative. Without a clear storyboard of what happened in the trial and why, the team ends up answering questions one at a time instead of showing a coherent, controlled program.

Complex trials make this more urgent

In oncology and hematology, novel mechanisms, adaptive designs, high-risk patient populations and fast-moving protocols create more deviations, more amendments and more decisions that need to be documented and defended. The more complex the trial, the more there is to explain, and the less time there is to work it out during an inspection.

What starting early actually looks like

• Build it into the quality system. Risk-based oversight, CAPA that actually closes root causes, and documentation that stands on its own should be routine, not a pre-inspection sprint.
• Audit ahead of the regulator. Independent GCP/GxP, vendor, site and system audits show you the gaps while there is still time to act on them.
• Run a mock inspection early enough to matter. Include front and back room simulation, mock interviews and real-time request handling, with enough runway to fix what you learn.
• Prepare the people, not just the files. Role-based training helps teams answer difficult questions calmly, accurately and consistently.
• Review the submission with an inspector’s eyes. Check that what you filed matches what happened in the trial.

The bottom line

The best inspection outcomes rarely come from a great final month. They come from a program that was inspection-ready long before anyone announced an inspection. If your readiness plan begins with the notification letter, it is probably starting too late.

Want to see the gaps before the inspectors do? Talk to the VedX Clinical team about a mock inspection, audit or readiness review at vedxclinical.com.